Charles River highlights increase in demand as tariff uncertainties fadenews2026-02-18T17:33:30+00:00February 18th, 2026|Endpoints News|
Lilly stockpiles $1.5B worth of weight loss pill ahead of US approvalnews2026-02-13T15:00:35+00:00February 13th, 2026|Endpoints News|
Novo Nordisk to expand Irish factory for Wegovy pillnews2026-02-12T17:55:57+00:00February 12th, 2026|Endpoints News|
Cassidy bill seeks to ban a customs loophole on pharma’s radarnews2026-02-12T16:58:11+00:00February 12th, 2026|Endpoints News|
UK attractive for investment, Fujifilm CEO says; Moderna’s Mexico dealnews2026-02-12T16:26:00+00:00February 12th, 2026|Endpoints News|
With scant data, RFK Jr. credits Trump for higher European drug pricesnews2026-02-09T20:44:29+00:00February 9th, 2026|Endpoints News|
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex news2026-02-05T15:22:33+00:00February 5th, 2026|Endpoints News|
FDA rejects Aquestive’s allergy drug over packaging issuesnews2026-02-02T15:17:06+00:00February 2nd, 2026|Endpoints News|
FDA opens submissions for PreCheck program to speed up US factory buildsnews2026-02-02T14:46:33+00:00February 2nd, 2026|Endpoints News|
Lilly unveils $3.5B factory that will make retatrutide and other obesity drugsnews2026-01-30T16:00:33+00:00January 30th, 2026|Endpoints News|
